Results 151 to 160 of about 71,439 (210)

Design, synthesis, <i>in silico</i> studies, and antiproliferative activity of a novel series of thiazole/1,2,3-triazole hybrids as apoptosis inducers and multi-kinase inhibitors endowed with anti-breast cancer activity. [PDF]

RSC Adv
Mohamed FAM, Alakilli SYM, Alhassan HH, Yousif SO, Alatwi E, Gomaa HAM, Alrub HA, Alyami BA, Abdelhafez AH, Bräse S, Youssif BGM.   +10 more
europepmc   +1 more source

Updates in the Management of EGFR-Mutated Non-small Cell Lung Cancer (NSCLC). [PDF]

Curr Oncol Rep
Vyas A, Jeon WJ, Alhushki S, Singhi E, Rous FA, Thawani R, Desai A.   +6 more
europepmc   +1 more source

Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma. [PDF]

Mol Cancer Ther
Zacharias NM, Ozambela M, Karki M, He R, Chauhan PK, Pesquera PI, Hernandez Gonzalez AE, Ochoa O, Pieretti A, Chen H, De La Cerda C, Yu Z, Grover A, Hicks-Peňa S, Fowlkes NW, Wang L, Maity T, Rao P, Genovese G, Tannir NM, Karam JA, Msaouel P.   +21 more
europepmc   +1 more source

Assessing first-line treatment for advanced EGFR-mutated NSCLC in diverse clinicopathological subgroups: a systematic review and network meta-analysis. [PDF]

BMC Cancer
Mei T, Wang T, Zhou Q.
europepmc   +1 more source

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines. [PDF]

Int J Mol Sci
Raungrut P, Tanyapattrapong S, Maungchanburi S, Bumrungchoo K.   +3 more
europepmc   +1 more source

High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma. [PDF]

J Exp Clin Cancer Res
Farrell A, Dall G, Vandenberg CJ, Shield-Artin K, Kyran EL, Blackmore T, Lim R, Taylor R, Neagle C, Ratnayake G, Tan T, Mouradov D, Hadla A, Jarman K, Beard S, Jarratt A, Penington JS, Wakefield MJ, Papenfuss AT, Scott CL, Barker HE.   +20 more
europepmc   +1 more source

Efficacy of Topical Beta-Blockers in Managing Epidermal Growth Factor Receptor Inhibitor-Related Paronychia and Pyogenic Granuloma-Like Lesion: A Systematic Review and Meta-Analysis. [PDF]

Cancer Med
Chan PK, Yen WT, Chen PH.
europepmc   +1 more source

Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis. [PDF]

Clin Med Insights Oncol
Wang Z, Guo Y, Qin X, Wan Z, Wu X, Liu C.   +5 more
europepmc   +1 more source

Successful treatment of an <i>MBTPS2</i>-linked Olmsted syndrome patient using erlotinib. [PDF]

JAAD Case Rep
Sadeghzadeh-Bazargan A, Khodakarim N, Liafuii MN, Zeinali R, Safaei A, Youssefian L, Dehghani A, Vahidnezhad H.   +7 more
europepmc   +1 more source

C1orf116 inhibits acquired resistance to EGFR inhibitors in EGFR mutant lung adenocarcinoma by suppressing the ATM/ATR pathways. [PDF]

Transl Lung Cancer Res
Wang F, Lu C, Yang X, Wei X, Luo W, Wu L, Yan H, Chen Z, Zhou Q.   +8 more
europepmc   +1 more source